Fanny, could you introduce yourself, please? Tell us what your perspective is on this.

So I'm working for UCB, being on the pharma side, taking care of the procurement organization for small molecule API.

And on our side, I think the post-COVID and all this geopolitical tension has been really a catalyst to think through how you want to kind of work in the future.

Regionalization, we are talking about split of volume.

And then you think about, okay, if we split volume, obviously on the procurement side, you're afraid because you are going to raise the cost.

But you can just look on another end, more on the total cost of ownership of a product.

And yesterday we were talking a little bit about this and looking at the entire supply chain and also see how being global around the region may have a positive or negative impact.

Fanny, what about your perspective on this, please? What are the sort of inputs that you need to decide whether to consolidate or not?